Merz Pharma is an independent international aesthetics and neurotoxin company with its own research and development capabilities. Our continued growth and market leadership in aesthetics and neurotoxins is the result of our drive for innovation, along with focused, strategic acquisitions. We have continued to expand across all areas of our business, due to a focused, purposeful approach that includes both organic and inorganic growth. As a privately-held and family-owned company with a 100 year-plus history, we believe in taking a long-term view. Merz brings an unwavering focus to the specialties we serve, combined with a flexible, responsive approach to the individualized needs of our physician customers and their patients.
Company Growth (employees)
Type
Private
HQ
Frankfurt Am Main, DE
Founded
1995
Size (employees)
738 (est)
Website
merz.com
Merz was founded in 1995 and is headquartered in Frankfurt am Main, DE

Key People/Management at Merz

Philip Burchard

Philip Burchard

Chief Executive Officer
Beat Neukom

Beat Neukom

Chief Financial Officer
Stefan Albrecht

Stefan Albrecht

Chief Scientific Officer
Katrina Church

Katrina Church

Chief Compliance Officer
Anke Frankenberger

Anke Frankenberger

Chief Legal Counsel
Bob Rhatigan

Bob Rhatigan

Region North America
Lawrence Siow

Lawrence Siow

Region Asia-Pacific
Torsten Wagner

Torsten Wagner

Global Technical Operations
Hans-Jörg Bergler

Hans-Jörg Bergler

Global Corporate Development, HR and Communications
Stefan Brinkmann

Stefan Brinkmann

Region EMEA

Merz Office Locations

Merz has offices in Frankfurt am Main, Dessau-Roßlau, Reinheim and Potsdam
Frankfurt am Main, DE (HQ)
100 Eckenheimer Landstraße
Dessau-Roßlau, DE
Am Pharmapark
Frankfurt am Main, DE
Alfred-Wegener-Straße
Potsdam, DE
15 Hermannswerder
Reinheim, DE
22 Ludwigstraße
Show all (5)

Merz Financials and Metrics

Summary Metrics

Founding Date

1995

Merz's Web-traffic and Trends

Merz News and Updates

Essential Tremor Treatment Market increasing demand with Leading key players: Merz Pharma GmbH & KgaA, Neurocrine Biosciences

HTF MI published a new industry research that focuses on Essential Tremor Treatment market and delivers in-depth market analysis and future prospects of Global Essential Tremor Treatment market. Posted via Industry Today. Follow us on Twitter @IndustryToday

Facial Injectable Market to Discern Magnified Growth During 2025

Changing perception of beauty all over the world is demanding the increased use of dermal fillers and other facial injectable. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Dental Material 2018 Industry Trends, Sales, Supply, Demand, Analysis & Forecast to 2023

Wiseguyreports.Com adds “Dental Material Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2023” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Facial Injectable 2017 Market Estimation, Dynamics, Outllook, Research, Trends and Forecasts to 2021

WiseGuyReports.Com adds  “Facial Injectable 2017 Market Estimation, Dynamics, Outllook, Research, Trends and Forecasts to 2021” Research to its Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Facial Rejuvenation Market to Reach US$ 26,585.6 Mn by 2021

Growth in the facial rejuvenation market is mainly driven by healthy economic growth witnessed in most countries, leading to rising in disposable income levels and lifestyle changes. Posted via Industry Today. Follow us on Twitter @IndustryToday

Stretch Marks Treatment Market to Record Sturdy Growth at 5.4% CAGR by 2025

Transparency Market Research has announced the addition of the “Stretch Marks Treatment Market: Global Industry Analysis and Opportunity Assessment, 2017-2025"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

Merz Company Life and Culture

You may also be interested in